Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Brougham

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|August 19, 2007
Medicines funding: Value for money is nothing newMatthew Brougham
Healthcarepapers|June 18, 2003
Our advice? Get a budget!Matthew Brougham, Scott Metcalfe, Wayne McNee
The New Zealand Medical Journal|March 27, 2003
PHARMAC measures savings elsewhere to the health sectorScott Metcalfe, Sean Dougherty, Matthew Brougham, et al.
The New Zealand Medical Journal|August 2, 2005
PHARMAC responds to Richard Milne on discounting health benefits and costsScott Metcalfe, Matthew Brougham, Peter Moodie, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|April 11, 2022
Use of the incremental cost-effectiveness ratio for decision-making policies-what is the problem? A perspective paperMatthew Brougham, Michael Schlander, Harry Telser, et al.
International Journal of Health Policy and Management|August 24, 2019
Moving Towards Accountability for Reasonableness - A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case StudyMonika Wagner, Dima Samaha, Roman Casciano, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|August 19, 2007
Medicines funding: Value for money is nothing newMatthew Brougham
Healthcarepapers|June 18, 2003
Our advice? Get a budget!Matthew Brougham, Scott Metcalfe, Wayne McNee
The New Zealand Medical Journal|March 27, 2003
PHARMAC measures savings elsewhere to the health sectorScott Metcalfe, Sean Dougherty, Matthew Brougham, et al.
The New Zealand Medical Journal|August 2, 2005
PHARMAC responds to Richard Milne on discounting health benefits and costsScott Metcalfe, Matthew Brougham, Peter Moodie, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|April 11, 2022
Use of the incremental cost-effectiveness ratio for decision-making policies-what is the problem? A perspective paperMatthew Brougham, Michael Schlander, Harry Telser, et al.
International Journal of Health Policy and Management|August 24, 2019
Moving Towards Accountability for Reasonableness - A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case StudyMonika Wagner, Dima Samaha, Roman Casciano, et al.
Pageof 1